Identifying molecular targets of lifestyle modifications in colon cancer prevention
- PMID: 23675573
- PMCID: PMC3653120
- DOI: 10.3389/fonc.2013.00119
Identifying molecular targets of lifestyle modifications in colon cancer prevention
Abstract
One in four deaths in the United States is cancer-related, and colorectal cancer (CRC) is the second leading cause of cancer-associated deaths. Screening strategies are utilized but have not reduced disease incidence or mortality. In this regard, there is an interest in cancer preventive strategies focusing on lifestyle intervention, where specific etiologic factors involved in cancer initiation, promotion, and progression could be targeted. For example, exposure to dietary carcinogens, such as nitrosamines and polycyclic aromatic hydrocarbons influences colon carcinogenesis. Furthermore, dietary deficiencies could alter sensitivity to genetic damage and influence carcinogen metabolism contributing to CRC. High alcohol consumption increases the risk of mutations including the fact that acetaldehyde, an ethanol metabolite, is classified as a group 1 carcinogen. Tobacco smoke exposure is also a risk factor for cancer development; approximately 20% of CRCs are associated with smoking. Additionally, obese patients have a higher risk of cancer development, which is further supported by the fact that physical activity decreases CRC risk by 55%. Similarly, chronic inflammatory conditions also increase the risk of CRC development. Moreover, the circadian clock alters digestion and regulates other biochemical, physiological, and behavioral processes that could influence CRC. Taken together, colon carcinogenesis involves a number of etiological factors, and therefore, to create effective preventive strategies, molecular targets need to be identified and beleaguered prior to disease progression. With this in mind, the following is a comprehensive review identifying downstream target proteins of the above lifestyle risk factors, which are modulated during colon carcinogenesis and could be targeted for CRC prevention by novel agents including phytochemicals.
Keywords: colorectal cancer; grape seed extract; lifestyle modification; molecular targets; phytochemicals; prevention; silibinin.
Figures






Similar articles
-
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1. Ont Health Technol Assess Ser. 2009. PMID: 23074514 Free PMC article.
-
Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved.Biotechnol Adv. 2020 Jan-Feb;38:107322. doi: 10.1016/j.biotechadv.2018.11.011. Epub 2018 Nov 23. Biotechnol Adv. 2020. PMID: 30476540 Review.
-
Colorectal carcinogenesis--update and perspectives.World J Gastroenterol. 2014 Dec 28;20(48):18151-64. doi: 10.3748/wjg.v20.i48.18151. World J Gastroenterol. 2014. PMID: 25561783 Free PMC article. Review.
-
Colorectal Cancer Genetics, Incidence and Risk Factors: In Search for Targeted Therapies.Cancer Manag Res. 2020 Oct 9;12:9869-9882. doi: 10.2147/CMAR.S251223. eCollection 2020. Cancer Manag Res. 2020. PMID: 33116845 Free PMC article. Review.
-
Lifestyle Modifications and Colorectal Cancer.Curr Colorectal Cancer Rep. 2014;10(1):45-54. doi: 10.1007/s11888-013-0203-4. Curr Colorectal Cancer Rep. 2014. PMID: 24659930 Free PMC article. Review.
Cited by
-
Silibinin and colorectal cancer chemoprevention: a comprehensive review on mechanisms and efficacy.J Biomed Res. 2016 Nov;30(6):452-465. doi: 10.7555/JBR.30.20150111. Epub 2015 Nov 20. J Biomed Res. 2016. PMID: 27476880 Free PMC article. Review.
-
Contributing factors common to COVID‑19 and gastrointestinal cancer.Oncol Rep. 2022 Jan;47(1):16. doi: 10.3892/or.2021.8227. Epub 2021 Nov 15. Oncol Rep. 2022. PMID: 34779496 Free PMC article. Review.
-
Alcohol induces cell proliferation via hypermethylation of ADHFE1 in colorectal cancer cells.BMC Cancer. 2014 May 28;14:377. doi: 10.1186/1471-2407-14-377. BMC Cancer. 2014. PMID: 24886599 Free PMC article.
-
Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.Semin Cancer Biol. 2016 Oct;40-41:116-129. doi: 10.1016/j.semcancer.2016.07.002. Epub 2016 Jul 21. Semin Cancer Biol. 2016. PMID: 27452666 Free PMC article. Review.
-
The prognostic significance of polymorphisms in hMLH1/hMSH2 for colorectal cancer.Med Oncol. 2014 Jun;31(6):975. doi: 10.1007/s12032-014-0975-7. Epub 2014 May 4. Med Oncol. 2014. PMID: 24793746
References
-
- Agarwal C., Singh R. P., Dhanalakshmi S., Tyagi A. K., Tecklenburg M., Sclafani R. A., et al. (2003). Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 22, 8271–828210.1038/sj.onc.1207158 - DOI - PubMed
-
- Akagi Y., Liu W., Zebrowski B., Xie K., Ellis L. M. (1998). Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I. Cancer Res. 58, 4008–4014 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources